{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T14:00:49Z","timestamp":1791986449922,"version":"4.4.0"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100007937","name":"Peking University First Hospital","doi-asserted-by":"publisher","award":["2019SF01"],"award-info":[{"award-number":["2019SF01"]}],"id":[{"id":"10.13039\/501100007937","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007937","name":"University Medicine Fund of Fostering Young Scholars \u2019Scientific & Technological Innovation","doi-asserted-by":"publisher","award":["BMU2018PYB001"],"award-info":[{"award-number":["BMU2018PYB001"]}],"id":[{"id":"10.13039\/501100007937","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014239","name":"Fundamental Research Funds for the Central Universities","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014239","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Letters"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1016\/j.canlet.2019.09.006","type":"journal-article","created":{"date-parts":[[2019,9,19]],"date-time":"2019-09-19T19:09:19Z","timestamp":1568920159000},"page":"49-60","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":63,"special_numbering":"C","title":["Inhibition of hydrogen sulfide synthesis reverses acquired resistance to 5-FU through miR-215-5p-EREG\/TYMS axis in colon cancer cells"],"prefix":"10.1016","volume":"466","author":[{"given":"Shanwen","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taohua","family":"Yue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhihao","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dingfang","family":"Bu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yisheng","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yucun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pengyuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.canlet.2019.09.006_bib1","first-page":"394","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray","year":"2018","journal-title":"CA A Cancer J. Clin."},{"issue":"6","key":"10.1016\/j.canlet.2019.09.006_bib2","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/s41568-019-0142-8","article-title":"Cancer overdiagnosis: a biological challenge and clinical dilemma","volume":"19","author":"Srivastava","year":"2019","journal-title":"Nat. Rev. Cancer"},{"issue":"2","key":"10.1016\/j.canlet.2019.09.006_bib3","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.critrevonc.2013.08.015","article-title":"Methods of overcoming treatment resistance in colorectal cancer","volume":"89","author":"Temraz","year":"2014","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"10.1016\/j.canlet.2019.09.006_bib4","doi-asserted-by":"crossref","DOI":"10.1007\/s00018-019-03134-0","article-title":"Drug repurposing to overcome resistance to various therapies for colorectal cancer","author":"Fong","year":"2019","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.canlet.2019.09.006_bib5","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1038\/nrd.2015.1","article-title":"Gasotransmitters in cancer: from pathophysiology to experimental therapy","volume":"15","author":"Szabo","year":"2016","journal-title":"Nat. Rev. Drug Discov."},{"issue":"8","key":"10.1016\/j.canlet.2019.09.006_bib6","doi-asserted-by":"crossref","first-page":"4145","DOI":"10.1096\/fj.201701095R","article-title":"Cystathionine \u03b2-synthase regulates mitochondrial morphogenesis in ovarian cancer","volume":"32","author":"Chakraborty","year":"2018","journal-title":"FASEB J."},{"key":"10.1016\/j.canlet.2019.09.006_bib7","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.freeradbiomed.2015.05.024","article-title":"Role of cystathionine \u03b2-synthase in human breast Cancer","volume":"86","author":"Sen","year":"2015","journal-title":"Free Radic. Biol. Med."},{"issue":"30","key":"10.1016\/j.canlet.2019.09.006_bib8","doi-asserted-by":"crossref","first-page":"12474","DOI":"10.1073\/pnas.1306241110","article-title":"Tumor-derived hydrogen sulfide, produced by cystathionine-\u03b2-synthase, stimulates bioenergetics, cell proliferation, and angiogenesis in colon cancer","volume":"110","author":"Szabo","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"21","key":"10.1016\/j.canlet.2019.09.006_bib9","doi-asserted-by":"crossref","first-page":"5741","DOI":"10.1158\/0008-5472.CAN-16-3480","article-title":"Upregulation of cystathionine-\u03b2-synthase in colonic epithelia reprograms metabolism and promotes carcinogenesis","volume":"77","author":"Phillips","year":"2017","journal-title":"Cancer Res."},{"issue":"8","key":"10.1016\/j.canlet.2019.09.006_bib10","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1111\/bph.12369","article-title":"Regulation of mitochondrial bioenergetic function by hydrogen sulfide. Part I. Biochemical and physiological mechanisms","volume":"171","author":"Szabo","year":"2014","journal-title":"Br. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.canlet.2019.09.006_bib11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1089\/ars.2017.7058","article-title":"A review of hydrogen sulfide synthesis, metabolism, and measurement: is modulation of hydrogen sulfide a novel therapeutic for cancer?","volume":"31","author":"Cao","year":"2019","journal-title":"Antioxidants Redox Signal."},{"issue":"3","key":"10.1016\/j.canlet.2019.09.006_bib12","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.cgh.2018.04.015","article-title":"The association between mutations in BRAF and colorectal cancer-specific survival depends on microsatellite status and tumor stage","volume":"17","author":"Bl\u00e4ker","year":"2019","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"10.1016\/j.canlet.2019.09.006_bib13","doi-asserted-by":"crossref","first-page":"4641","DOI":"10.1002\/anie.201300841","article-title":"Identifcation of cystathionine \u03b2-synthase inhibitors using a hydrogen sulfde selective probe","volume":"52","author":"Thorson","year":"2013","journal-title":"Angew Chem. Int. Ed. Engl."},{"issue":"2","key":"10.1016\/j.canlet.2019.09.006_bib14","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1158\/0008-5472.CAN-09-1947","article-title":"Drug combination studies and their synergy quantification using the Chou-Talalay method","volume":"70","author":"Chou","year":"2010","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.canlet.2019.09.006_bib15","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.canlet.2011.10.019","article-title":"Characterization of two mouse models of metastatic pheochromocytoma using bioluminescence imaging","volume":"316","author":"Giubellino","year":"2012","journal-title":"Cancer Lett."},{"issue":"1","key":"10.1016\/j.canlet.2019.09.006_bib16","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.cell.2018.03.001","article-title":"Amino acid restriction triggers angiogenesis via GCN2\/ATF4 regulation of VEGF and H2S production","volume":"173","author":"Longchamp","year":"2018","journal-title":"Cell"},{"issue":"W1","key":"10.1016\/j.canlet.2019.09.006_bib17","doi-asserted-by":"crossref","first-page":"W98","DOI":"10.1093\/nar\/gkx247","article-title":"GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses","volume":"45","author":"Tang","year":"2017","journal-title":"Nucleic Acids Res."},{"issue":"11","key":"10.1016\/j.canlet.2019.09.006_bib18","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1002\/gcc.20811","article-title":"Mutated KRAS results in overexpression of DUSP4, a MAP-kinase phosphatase, and SMYD3, a histone methyltransferase, in rectal carcinomas","volume":"49","author":"Gaedcke","year":"2010","journal-title":"Genes Chromosomes Cancer"},{"issue":"3","key":"10.1016\/j.canlet.2019.09.006_bib19","doi-asserted-by":"crossref","first-page":"R19","DOI":"10.1186\/gb-2006-7-3-r19","article-title":"Deciphering cellular states of innate tumor drug responses","volume":"7","author":"Graudens","year":"2006","journal-title":"Genome Biol."},{"issue":"5","key":"10.1016\/j.canlet.2019.09.006_bib20","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1053\/j.gastro.2017.12.022","article-title":"Hedgehog-yap signaling pathway regulates glutaminolysis to control activation of hepatic stellate cells","volume":"154","author":"Du","year":"2018","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1016\/j.canlet.2019.09.006_bib21","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1089\/ars.2014.5933","article-title":"The therapeutic potential of cystathionine \u03b2-synthetase\/hydrogen sulfide inhibition in cancer","volume":"22","author":"Hellmich","year":"2015","journal-title":"Antioxidants Redox Signal."},{"issue":"2","key":"10.1016\/j.canlet.2019.09.006_bib22","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.canlet.2012.10.004","article-title":"The \u03b26-integrin-ERK\/MAP kinase pathway contributes to chemo resistance in colon cancer","volume":"328","author":"Liu","year":"2013","journal-title":"Cancer Lett."},{"issue":"3","key":"10.1016\/j.canlet.2019.09.006_bib23","doi-asserted-by":"crossref","first-page":"970","DOI":"10.4143\/crt.2015.140","article-title":"In vitro adenosine triphosphate-based chemotherapy response assay as a predictor of clinical response to fluorouracil-based adjuvant chemotherapy in stage II colorectal cancer","volume":"48","author":"Kwon","year":"2016","journal-title":"Cancer Res Treat"},{"issue":"2","key":"10.1016\/j.canlet.2019.09.006_bib24","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.canlet.2009.10.013","article-title":"Triptolide simultaneously induces reactive oxygen species, inhibits NF-kappaB activity and sensitizes 5-fluorouracil in colorectal cancer cell lines","volume":"291","author":"Xu","year":"2010","journal-title":"Cancer Lett."},{"issue":"4","key":"10.1016\/j.canlet.2019.09.006_bib25","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1124\/pr.117.014050","article-title":"International union of basic and clinical pharmacology. CII: pharmacological modulation of H2S levels: H2S donors and H2S biosynthesis inhibitors","volume":"69","author":"Szabo","year":"2017","journal-title":"Pharmacol. Rev."},{"issue":"3","key":"10.1016\/j.canlet.2019.09.006_bib26","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1038\/nrd.2015.1","article-title":"Gasotransmitters in cancer: from pathophysiology to experimental therapy","volume":"15","author":"Szabo","year":"2016","journal-title":"Nat. Rev. Drug Discov."},{"issue":"9","key":"10.1016\/j.canlet.2019.09.006_bib27","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.1007\/s10620-017-4681-0","article-title":"Gaseous mediators in gastrointestinal mucosal defense and injury","volume":"62","author":"Wallace","year":"2017","journal-title":"Dig. Dis. Sci."},{"issue":"8","key":"10.1016\/j.canlet.2019.09.006_bib28","doi-asserted-by":"crossref","first-page":"4145","DOI":"10.1096\/fj.201701095R","article-title":"Cystathionine \u03b2-synthase regulates mitochondrial morphogenesis in ovarian cancer","volume":"32","author":"Chakraborty","year":"2018","journal-title":"FASEB J."},{"issue":"7","key":"10.1016\/j.canlet.2019.09.006_bib29","first-page":"3423","article-title":"Increased nicotinamide phosphoribosyltransferase and cystathionine-\u03b2-synthase in renal oncocytomas, renal urothelial carcinoma, and renal clear cell carcinoma","volume":"37","author":"Shackelford","year":"2017","journal-title":"Anticancer Res."},{"key":"10.1016\/j.canlet.2019.09.006_bib30","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.freeradbiomed.2015.05.024","article-title":"Role of cystathionine \u03b2-synthase in human breast Cancer","volume":"86","author":"Sen","year":"2015","journal-title":"Free Radic. Biol. Med."},{"issue":"21","key":"10.1016\/j.canlet.2019.09.006_bib31","doi-asserted-by":"crossref","first-page":"5741","DOI":"10.1158\/0008-5472.CAN-16-3480","article-title":"Upregulation of cystathionine-\u03b2-synthase in colonic epithelia reprograms metabolism and promotes carcinogenesis","volume":"77","author":"Phillips","year":"2017","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.canlet.2019.09.006_bib32","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.cell.2018.03.001","article-title":"Amino acid restriction triggers angiogenesis via GCN2\/ATF4 regulation of VEGF and H2S production","volume":"173","author":"Longchamp","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.canlet.2019.09.006_bib33","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.bcp.2017.10.007","article-title":"Drug resistance induces the upregulation of H2S-producing enzymes in HCT116 colon cancer cells","volume":"149","author":"Untereiner","year":"2018","journal-title":"Biochem. Pharmacol."}],"container-title":["Cancer Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383519304707?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383519304707?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T15:44:20Z","timestamp":1759592660000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304383519304707"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":33,"alternative-id":["S0304383519304707"],"URL":"https:\/\/doi.org\/10.1016\/j.canlet.2019.09.006","relation":{},"ISSN":["0304-3835"],"issn-type":[{"value":"0304-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2019,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inhibition of hydrogen sulfide synthesis reverses acquired resistance to 5-FU through miR-215-5p-EREG\/TYMS axis in colon cancer cells","name":"articletitle","label":"Article Title"},{"value":"Cancer Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canlet.2019.09.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}